190 related articles for article (PubMed ID: 37289979)
1. Disease-Modifying Effects of Vincamine Supplementation in
Sanz FJ; Solana-Manrique C; Paricio N
ACS Chem Neurosci; 2023 Jun; 14(12):2294-2301. PubMed ID: 37289979
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency.
Solana-Manrique C; Sanz FJ; Ripollés E; Bañó MC; Torres J; Muñoz-Soriano V; Paricio N
Free Radic Biol Med; 2020 Oct; 158():137-148. PubMed ID: 32726690
[TBL] [Abstract][Full Text] [Related]
4. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson's Disease Treatment.
Sanz FJ; Solana-Manrique C; Torres J; Masiá E; Vicent MJ; Paricio N
Neurotherapeutics; 2021 Oct; 18(4):2565-2578. PubMed ID: 34697772
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease.
Solana-Manrique C; Muñoz-Soriano V; Sanz FJ; Paricio N
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166152. PubMed ID: 33892078
[TBL] [Abstract][Full Text] [Related]
6. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
7. Drosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO.
Hwang S; Song S; Hong YK; Choi G; Suh YS; Han SY; Lee M; Park SH; Lee JH; Lee S; Bang SM; Jeong Y; Chung WJ; Lee IS; Jeong G; Chung J; Cho KS
PLoS Genet; 2013 Apr; 9(4):e1003412. PubMed ID: 23593018
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Alterations in a
Solana-Manrique C; Sanz FJ; Torregrosa I; Palomino-Schätzlein M; Hernández-Oliver C; Pineda-Lucena A; Paricio N
Cells; 2022 Jan; 11(3):. PubMed ID: 35159141
[TBL] [Abstract][Full Text] [Related]
9. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila.
Sanz FJ; Solana-Manrique C; Lilao-Garzón J; Brito-Casillas Y; Muñoz-Descalzo S; Paricio N
FASEB J; 2022 Aug; 36(8):e22432. PubMed ID: 35766235
[TBL] [Abstract][Full Text] [Related]
10. Cistanche extracts ameliorates the neurotoxicity induced by hydrogen peroxide in new mutant DJ-1-transfected neuroblastoma cellular models.
An C; Pu X; Wang Q; Zhang H
Brain Behav; 2019 Jul; 9(7):e01304. PubMed ID: 31216127
[TBL] [Abstract][Full Text] [Related]
11. Lessons from Drosophila models of DJ-1 deficiency.
Moore DJ; Dawson VL; Dawson TM
Sci Aging Knowledge Environ; 2006 Jan; 2006(2):pe2. PubMed ID: 16407572
[TBL] [Abstract][Full Text] [Related]
12. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease.
Meulener M; Whitworth AJ; Armstrong-Gold CE; Rizzu P; Heutink P; Wes PD; Pallanck LJ; Bonini NM
Curr Biol; 2005 Sep; 15(17):1572-7. PubMed ID: 16139213
[TBL] [Abstract][Full Text] [Related]
13. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction.
Park J; Kim SY; Cha GH; Lee SB; Kim S; Chung J
Gene; 2005 Nov; 361():133-9. PubMed ID: 16203113
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.
Skou LD; Johansen SK; Okarmus J; Meyer M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391909
[TBL] [Abstract][Full Text] [Related]
15. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease.
Casani S; Gómez-Pastor R; Matallana E; Paricio N
Free Radic Biol Med; 2013 Aug; 61():151-60. PubMed ID: 23548634
[TBL] [Abstract][Full Text] [Related]
17. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
18. DJ-1-dependent protective activity of DJ-1-binding compound no. 23 against neuronal cell death in MPTP-treated mouse model of Parkinson's disease.
Takahashi-Niki K; Inafune A; Michitani N; Hatakeyama Y; Suzuki K; Sasaki M; Kitamura Y; Niki T; Iguchi-Ariga SM; Ariga H
J Pharmacol Sci; 2015 Mar; 127(3):305-10. PubMed ID: 25837927
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency.
Nam Y; Na J; Ma SX; Park H; Park H; Lee E; Kim H; Jang SM; Ko HS; Kim S
Genes Genomics; 2024 May; 46(5):519-529. PubMed ID: 38460098
[TBL] [Abstract][Full Text] [Related]
20. Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1beta mutants.
Lavara-Culebras E; Muñoz-Soriano V; Gómez-Pastor R; Matallana E; Paricio N
Gene; 2010 Aug; 462(1-2):26-33. PubMed ID: 20423725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
